A Review of Analytical Method Validation:
Current Regulatory Guidelines and Practical Challenges
Nakul B. Salunkhe1*, Kunal S. Salunkhe1, Amol R. Pawar1,2*, Pankaj S. Patil1, Vikas V. Patil1
1Department of Quality Assurance, Kisan Vidya Prasarak Sanstha’s,
Institute of Pharmaceutical Education, Boradi 425428.
2Research Scholar, Sankalchand Patel University, Visnagar – 384315 (Gujarat - India).
*Corresponding Author E-mail: ipebboradi@gmail.com
ABSTRACT:
Manufacturing consistently high-quality products at the lowest feasible cost is the main goal of any pharmaceutical plant1. Even though the pharmaceutical sector has long carried out validation studies, interest in the practice is growing because of the industry's increased focus on quality assurance programs in recent years, which are essential to an effective production operation. In the United States, the idea of validation began to take shape in 1978.2
Definition of Validation:
FDA (Food and Drug Administration) define validation as a production and process control procedure intended to ensure that drug products possess their identity, strength, quality, and purity. The validation package must contain the data and test methods needed to demonstrate that the system and the process satisfy the requirements, per FDA guidelines from May 1987.3
Needs of Validation:
1. Prior to using a new technique on a regular basis, validation is required.
2. Whenever the circumstances that have been used to validate a method change.
3. Whenever the metod is changed and the change is outside the original scope of method.
Importance of Validation:
· During validation knowledge of process increases.
· Assures the repeatability of the process.
· Assures the fluency of production.
· Decreases the risk of the manufacturing problem.
· Decreases the expenses caused by failure in production.
· Decreases the risk of failure in GMP.
· Decreases the expenses of every day production.
Method Validation:
Almost every day in the pharmaceutical sector, analysis must validate an analytical method since approved regulatory filings require methods that have been sufficiently verified. However, since there isn't a single industry standard for assay validation, analysts cannot agree on what defines a validated procedure. Regulatory bodies, industry committees, and the literature have all given method validation a lot of attention. The validation of analytical processes is the subject of a consensus document created by the International Conference on Harmonization (ICH) on technical requirements for the registration of medicines for human use. Multi-laboratory studies are used to validate the methods provided by the US Environmental Protection Agency (US EPA), Resource Conservation and Recovery Act (RCRA), American Association of Official Analytical Chemists (AOAC), USP, and other scientific organizations4. Regarding the submission of analytical and sample data for methods validation, the US Food and Drug Administration (US FDA) has put forward rules. There are particular recommendations for technique validation and substance evaluation issued by the United States Pharmacopoeia (USP).5
Types of The Validation:
1. Process Validation.
2. Analytical Method Validation.
3. Cleaning Validation.
4. Computerized System Validation.
1. Process Validation:
Attractive attributes. Process validation is done to achieve these6. While the product is being manufactured, the production process should be flexible with some limitations.
Goals of Process Validation:
1. It offers the assurance of high quality, which is desired by the industry.
2. For reducing the variance between batches.
3. Because retesting and reprocessing save time and money.
4. For the procedure that satisfies the robustness requirements.
5. for the product's reliable production and the reproducibility of the procedure.
6. decrease in costs as a result of a product flaw.
7. In order to comply with regulations.
8. in order to prove the drugs' higher quality.
2. Analytical Method Validation:
Validation that takes the analytical process into account is a basic prerequisite for the chemical assessment. Method validation involves conducting numerous assessments to determine whether an analysis method can produce a measurement that is both profitable and compliant with regulations, as well as whether it offers the anticipated explanation. The process complies with the guidelines and suggestionsshould yield useful information that guarantees the product's quality. Such results are determined by testing the sample multiple times. A thoroughly validated approach should meet every requirement. In order to validate the analytical method, the excipients should be tested, with an emphasis on standard testing circumstances. The validation of the analytical method is specific to the product, as demonstrated by all of these conditions.7
Objectives of Analytical Method Validation:
1. Further validation is not necessary when the formulation or concentration is changed, provided that the analytical method is validated first.
2. The risk of non-compliance with regulations is reduced.
3. The analytical method makes it possible to completely understand the process's critical parameters.
4. minimizing the impact of interference on precision and accuracy.
5. It is employed in product authorization and marketing licensing for novel, non-pharmacopeia items.
3. Cleaning Validation:
Validating the cleaning procedure is the only way to ensure that the product is free of contamination, which is crucial. The cleaning method should ensure that everything undesirable is removed from the equipment and facilities used during the process. There should be less undesired contamination than what is required by law. Validation and cleaning are essential processes in the medication manufacture. There are various analytical methods for validating the cleaning procedure. To confirm that the equipment is clean, the swab test is the most widely used methodComputer systems can be utilized to operate machinery and equipment. The creation of acknowledgment measures should also be made clearer by the certification of the cleaning procedure. It is important to use the proper sample technique. The essential requirements are to be free from both chemical and microbiological contaminants. It is recommended that the contaminants be below the detection limit.8
Below is a list of the cleaning validation's objectives:
1. It is possible to satisfy the client's needs and satisfy them.
2. It is possible to reduce the amount of contamination brought on by bacteria, chemicals, and even API cross-contamination.
3. One can benefit from the drug's grantee being safe and pure.
4. It is possible to provide consistency between the product and the API.
4 Computerized System Validation:
Computer systems are becoming more well-known worldwide these days. This computer system is not isolated from the pharmaceutical industry. Computer systems are an integral aspect of the pharmaceutical industry, from the RandD stage to the creation of the production system. Equipment and machinery can be operated by computer systems. The definition of validation discusses the applicability of the validation in all areas of the pharmaceutical industry, including documentation, quality control in production, and storage. In addition to the computer program and system, computerized system validation also refers to the method's procedure. Validation occurs when the necessary specifications are met while the medication is being produced [9]. Computerized system validation refers to the process rather than the application of the system of the computer. The validation must cover its relation with other system and the system management. It should be user friendly. Documentation of all the process, training, validation, method operation of the machines, the equipment and system, etc. should be protected by using this system. It is totally related to computer system. For the validation activities, much effort is expected within the industry.10
Validation Parameters:
The FDA guidelines state that the following phrases are frequently used in method validation.
1. Accuracy: The degree to which the nominal or known real concentration and the observed concentration are similar. It is commonly represented as a percentage of relative error (RE).
2. Precision: Measurement of scattering for the quantities found in a homogenous sample taken by duplicate sampling. Usually, it is expressed as the coefficient of variation (%CV).
3 Selectivity: The bioanalytical approach enables the measurement and distinction of the analyte in the presence of possibly present components. These could be degradants, pollutants, metabolites, or matrix elements.
4. Sensitivity: (LLOQ Lower Limit of Quantitation): The minimum analyte concentration in a sample that can be quantitatively identified with a satisfactory level of accuracy and precision.
5. Standard Curve: The correlation between the analytical concentration and the experimental response value.
6. Linearity: The bioanalytical process's capacity to produce test findings that fall within the standard curve's range and are exactly proportionate to the analyte concentration in the sample.
7. Quantification Range: The concentration range, which includes the LLOQ and ULOQ, that can be accurately and precisely measured using a concentration-response relationship in a reliable and repeatable manner.
8. Recovery: The percentage of an analyte's known amount that is extracted during the sample extraction and processing stages of an analytical procedure is known as the extraction efficiency.
9. Matrix Factor: A mass spectrometric detector's matrix effects caused by ionization suppression or amplification quantified.
10. Stability: An analyte's physical or chemical stability in a particular matrix under particular circumstances for specified periods of time.
11. Reproducibility: The method's capacity to provide a sample with a comparable concentration when measured at various times.11
Regulatory Guidelines:
Overview of Global Regulatory Bodies:
Every sector has established standards for worldwide regulatory authorities to validate analytical techniques in order to guarantee that the analytical data is rigorously regulated, accurate, consistent, and dependable. The purpose of these frameworks is to guarantee that analytical methods are widely recognized by standardizing validation procedures.
ICH Guidelines (Q2) (R2):
The "Validation of Analytical Procedures: Text and Methodology" Q2(R1) directive was created by the International Council for the Harmonization of Technical Standards for Human Use Pharmaceuticals (ICH). In order to validate analytical processes used in registration applications in the US, Japan, and the EU, this guideline specifies validation features. The showing that the analytical process is appropriate for its intended use, including accuracy, precision, specificity, detection limit, quantitation limit, linearity, and range, is known as validation. The ICH Q2(R1) guideline is crucial for standardizing analytical validation standards in order to decrease the need for redundant testing and ensure data mutual acceptance among regulatory authorities. In order to reduce drug development processes and expedite time to market in many locations, pharmaceutical companies find this harmonization to be crucial.
USP Standards:
The USP, or United States Pharmacopeia, provides guidance on the validation of compendial techniques in "Validation of Compendial Procedures." This chapter describes the qualities to be taken into account for different test types and the supporting documentation needed for analytical techniques submitted for inclusion in the USP-NF. It closely resembles the ICH Q2(R1) guideline, which covers factors including specificity, accuracy, precision, linearity, range, robustness, detection limit, and quantitation limit (USP, 2021). The UP emphasizes the implementation of system suitability tests, which entails running the test samples through the analytical system first to ensure that it is functioning correctly. The purpose of these tests is to confirm that the system's resolution, sensitivity, and reproducibility are sufficient for the planned analysis.12
EMA Regional Guidelines:
The ICH Q2(R1) guideline is used within the European Union since it was adopted by the EU. This guideline is significant because it exemplifies a standardized procedure for validating analytical methods throughout EMA member nations. Other regulatory bodies outside of the ICH regions have developed their own set of rules or guidelines that are comparable to the ICH but tailored to local demands. For instance, the World Health Organization (WHO) advises that analytical methods used to analyze pharmaceutical chemicals be verified, appropriate for their intended use, and produce accurate results.12
Challenges in Method Validation:
Validating analytical methods is becoming more and more important in order to get correct data for food inspection, environmental controls, and pharmaceuticals. The regulation of sensitivity and specificity, matrix interference in competent samples, and differences in instrumentation and procedure are a few of the difficulties. On the other hand, in this instance, method transfer can also be difficult. Transferring lab methods from one lab to another can be challenging. These variables are recognized to have an impact on the analytical results, and in order to guarantee that the methods are correct and consistent, they must be addressed when applied in various contexts or applications.
Variability in Instrument and Techniques:
Variability in analytical techniques and instruments makes method validation difficult. Variations in the instrument model, the state of maintenance, and the operational parameters can all lead to inconsistently positive outcomes. Temperature control, detector sensitivity, and calibration can all impair analytical precision and accuracy. Only thorough calibration procedures and regular failure maintenance can resolve these issues. Standard operating procedures (SOPs) are used to compare the outcomes of one instrument or operator with those of another. Pre-analysis system suitability tests can also be utilized to confirm the instrument's functionality and lower variability.13
Matrix Effects in Complex Sample:
When components of the solution reduce or increase a reaction to a target analyte, this is known as a matrix effect. The phenomena is especially noticeable in complex matrices, as those found in food goods, environmental samples, or biological fluids. Ion suppression or enhancement caused by co-eluting compounds in mass spectrometry can lead to imprecise quantification.
The proper preparation of samples and procedure optimization are necessary to address matrix effects. Methods like liquid liquid extraction (LLE), solid phase extraction (SPE), and the application of matrix-matched calibration standards can all help lessen these effects. Nevertheless, chromatographic separation prior to the detection stage can also improve the specificity and accuracy of the approach by reducing the coelution of interfering compounds.14
Specificity and Balancing Sensitivity:
The issues of sensitivity versus. specificity is frequently encountered in method validation, and there is no ideal ratio between the two. Furthermore, it is extremely sensitive, which means that it can identify analytes at low concentrations—a crucial feature of trace analysis. Despite the possibility of false positives as a result of drug interference, this sensitivity is not as high as that of a mass spectrometer. This allows method developers to optimize detection settings as well as choose appropriate analytical techniques to optimize these parameters. Specificity is provided by tandem mass spectrometry (MS/MS) which provides structural information to allow low interference. In addition, the specific chromatographic conditions are optimized to further improve the sensitivity and selectivity.15
Handling Method Transfers Between Laboratories:
When techniques are moved from one lab to another, reproducibility and consistency present challenges for analytical procedures. Equipment, ambient factors, and analyst skill all affect how well a procedure works. Ensuring that a validated approach yields comparable outcomes in many contexts is crucial for both regulatory compliance and collaborative research.16
To ensure successful method transfers, a procedure for method transfers should be developed including acceptance criteria and crucial parameters. The method's parts that vary from lab to lab and assist guarantee correctness in various settings can be fixed with the aid of inter laboratory validation studies. Method transfers may be further strengthened by staff training and material and equipment uniformity.17
Emerging Trends and Innovations:
Analytical technique validation is currently in flux due to technological advancements and regulatory changes. New trends and innovations are rewriting the way validation procedures are carried out, and automation, artificial intelligence, machine learning, and Quality by Design (QbD) frameworks are changing the way things are done. By definition, these advances improve dependability, efficiency, and adherence to legal requirements.
Automation in Method Validation:
The use of automation in analytical technique validation is growing as a result of its ability to decrease human error, enhance repeatability, and boost process efficiency. Automated systems have demonstrated the ability to do repetitive activities more accurately and quickly than manual procedures, including data analysis, method optimization, and sample preparation.18 Multiple approaches are validated at the same time using robotic equipment, liquid handling platforms, and automated software tools to conduct high throughput investigations. Given the time and legal constraints on quick and accurate validation procedures in the biotechnology and pharmaceutical sectors, this is particularly helpful. Defects can also be identified in real time thanks to real-time data collection and monitoring 19
Use of Artificial Intelligence and Machine Learning:
Analytical method validation is being replaced by intelligent filling, analysis, and prediction tools that replace human, repetitive labor due to AI and ML. By identifying patterns in a given data set and the links between variables and methods, these technologies enable an ML model to more accurately predict how changes in those factors will impact the performance of the methods. There is therefore less need for several experimental trial tests.20 The various AI-enabled solutions offer enhanced trend analysis, decreased forecast mistakes, and improved loss data outlier detection. Software integration between spectroscopy and chromatography aids in the detection and description of peaks in samples that contain components that elute identically. Furthermore, because techniques can change over time in response to new real data and/or regulatory elements, AI provides adaptively validated schemes, which improves analytical validation's flexibility and compliance.
Quality by Design Approach:
The QbD framework has been used to shift the focus of analytical method development and validation from a retrospective to a proactive manner. The International Council for Harmonization (ICH) developed the QbD technique, which incorporates quality from the outset. The target method profile (TMP) and critical method parameters (CMPs) that impact method performance are known as QbD. Researchers can use this information to develop low-variability, dependable methods.21 In order to optimize method conditions, QbD evaluates numerous variables at once using the Design of Experiments (DoE) component.
Analytical Quality by Design (AQBD) Application:
Analytical Quality by Design, or AQbD, is extended to analytical procedures in order to ensure their appropriateness, robustness, and dependability throughout their lifecycle. To find any weaknesses in analytical techniques, apply risk assessment techniques like Failure Mode and Effects Analysis (FMEA) in a scientific and risk-based approach.
One of AQbD's most significant benefits is its alignment with continuous validation. When techniques are used regularly, AQbD keeps an eye on their performance to make sure they remain valid even when sample matrices, apparatus, or ambient circumstances change. The strategy is founded on a lifecycle management approach to enhance regulatory compliance and lessen the need for regular revalidation.18
Case Study and Best Practices
Successful Validation of Chromatography Methods:
These methods, which are used extensively in analytical method validation to separate and quantify mixtures, include gas chromatography (GC) and high-performance liquid chromatography (HPLC). When used in the pharmaceutical sector to quantify active pharmaceutical ingredients (APIs), HPLC validation is a successful case study. It was shown that an HPLC method for a combination medication product comprising ibuprofen and paracetamol was valid.20 The technique met the ICH Q2(R1) requirements after being assessed for accuracy (recoveries 98–102%), precision (relative standard deviation < 2%), specificity (no excipient interference), and robustness (method unaffected by slight variations in pH and flow rate). A validation of GC techniques for the analysis of volatile organic compounds (VOC) in environmental monitoring is the second case. To find volatile organic compounds (VOCs) in industrial effluents, a GC-MS technique was employed. The procedure can be repeated, has a 0.1ppm limit of detection, and is appropriate for regulatory compliance.
Handling Analytical Method Lifecycle Management:
Analytical method lifecycle management guarantees the robustness and dependability of validated techniques while they are in use. The Analytical Quality by Design (AQbD) concept is necessary for lifecycle management. They demonstrated that continuous performance monitoring and occasional revalidation reduced the risks of environmental and instrument-related variability in their study of a stability-indicating HPLC method for an anti-diabetic drug. Control charts and other statistical methods for identifying patterns and abnormalities that arise during routine analysis were also highlighted in the study.
Robust documentation and risk assessment protocols are necessary to achieve successful lifecycle management, as described in ICH Q12, and the post-approval monitoring of analytical methods. Additionally, they ensure that your procedures adhere to evolving regulatory standards and reduce the number of individuals who must decide whether or not to revalidate.
CONCLUSION:
Analytical procedures must be validated for results to be accurate and reliable in a variety of organizations. Regulatory compliance is based on making sure that procedures and goods are safe, effective, and of high quality. The need to follow strict rules like ICH Q2(R1), USP, and EMA, which specify how important parameters like accuracy, precision, and robustness should be evaluated, is highlighted in this study. Technological developments like as automation, artificial intelligence, and AQbD offer a previously unheard-of chance for rapid solution validation and agility. There are still gaps, though, in areas like controlling matrix effects, striking a balance between sensitivity and specificity, and preserving consistent outcomes when transferring methods between labs. Increasingly, validated methods are being used in medicines, biologics, food safety, and environmental monitoring, all of which are vital to safeguarding public health. Future developments in green analytical chemistry, AQbD principles expansion, and AI-driven predictive analytics are required to fill in the gaps and satisfy changing regulatory framework requirements. In the present day, the integrity and reliability of analytical methods depend on a uniform global approach to technique validation and continuous innovation.
REFERANCE:
1. Naga G. R., Vignesh K. Analytical Method Validation: An Updated Review. IJAPBC. 2012; 1(1): 2012 G.
2. Lavanya, M. Sunil, and M. Eswarudu. Analytical Method Validation: an updated review. IJPSR. 2013; 4(4): 1280-1286.
3. Jaha S. M. Validation in Pharmaceutical Industry: Cleaning Validation - A Brief. 2017; 5(1).
4. The International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of analytical procedures, ICH-Q2A, Geneva 1995.
5. US FDA Technical Review Guide: Validation of Chromatographic Methods, Center for Drug Evaluation and Research (CDER), Rockville, MD, 4, 1993.
6. Borisagar, S. L., Patel, H. U., Patel, A. N., and Patel, C. N. A Validated HPLC Method for Estimation of Lornoxicam and Paracetamol in their Combined Tablet Dosage Form. International Journal of Pharmaceutical Sciences and Research. 2017: 1683-1686.
7. Chawal, G., and Chaudhary, K. A Review of HPLC Technique Covering its Pharmaceutical, Environmental, Forensic, Clinical and Other Applications. International Journal of Pharmaceutical Chemistry and Analysis. 2019; 6(2): 27-39.
8. Dash, D. K., and Vadher, M. Analytical Method Development and Validation for Simultaneous Determination of Zaltoprofen and Paracetamol in their Combined Solid Dosage Form By RP-HPLC Method. International Journal Of Pharmaceutical Sciences and Research. 2016; 5(12): 5255-5259.
9. DDA Guidelines. DDA Protocol for guidance and recommendation of documents.
10. Gaikwad, R., Chadhari, F., Kande, T., and Barge, V. Development and Validation of Analytical Method for Simultaneous Estimation of Paracetamol and Ibuprofen Using UV-Visible Spectroscopy. Human Journal Research Article. 2017
11. Surendra Bansal and Anthony DeStefano. Key elements of bio analytical method validation for small molecules. The AAPS Journal. 2007; 9(1): E109-E114.
12. Guy, R. C. (2014). International Conference on Harmonization.
13. Szopa, C., Meierhenrich, U. J., Coscia, D., Janin, L., Goesmann, F., Sternberg, R., and Rosenbauer, H. Gas chromatography for in situ analysis of a commentary nucleus: IV. Study of capillary column robustness for space application. Journal of Chromatography A. 2002; 982(2): 303-312.
14. Kruve, A., Künnapas, A., Herodes, K., and Leito, I. Matrix effects in pesticide multi-residue analysis by liquid chromatography-mass spectrometry. Journal of Chromatography A. 2008; 1187(1-2): 58-66.
15. Bjarnadóttir, S. G., and Flengsrud, R. Corrigendum to “Affinity chromatography, two-dimensional electrophoresis, adapted immunodepletion and mass spectrometry used for detection of porcine and piscine heparin-binding human plasma proteins. J. Chromatogr. B 2014; 944(2014): 107–113.
16. Huber, L. Validation of analytical methods. Pharmaceutical Technology. 2010; 24(9): 98–104.
17. Ermer, J., and Nethercote, P. W. (Eds.). (2014). Method validation in pharmaceutical analysis: A guide to best practice. John Wiley and Sons.
18. Lee, D. C., and Webb, M. (Eds.). (2008). Pharmaceutical analysis. John Wiley and Sons.
19. Khandagale, S. S., Bappasaheb, N. O., Khose, A. S., Kshirsagar, P., Nemane, P., and Thube, R. H. Role of Pharmaceutical Automation and Robotics in Pharmaceutical Industry: A Review. Systematic Reviews in Pharmacy. 2024; 15(3).
20. Olawade, D. B., Teke, J., Fapohunda, O., Weerasinghe, K., Usman, S. O., Ige, A. O., and David-Olawade, A. C. Leveraging artificial intelligence in vaccine development: A narrative review. Journal of Microbiological Methods. 2024; 106998.
21. Chiarentin, L., Gonçalves, C., Augusto, C., Miranda, M., Cardoso, C., and Vitorino, C. Drilling into the “Quality by Design” approach for analytical methods. Critical Reviews in Analytical Chemistry. 2024; 54(8): 3478-3519.
|
Received on 08.12.2025 Revised on 29.12.2025 Accepted on 15.01.2026 Published on 10.04.2026 Available online from April 13, 2026 Asian J. Research Chem.2026; 19(2):116-122. DOI: 10.52711/0974-4150.2026.00020 ©A and V Publications All Right Reserved
|
|
|
This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License. Creative Commons License. |
|